Neurotrope (NTRP) EBITDA margin US GAAP (year values) |
|||||||||
2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | -629.0% | -440.7% | -1 357% | -1 102% | ||||
Changes by years, y/y, % | +188pp | -916pp | +46.9% |
Neurotrope. EBITDA margin, %
Neurotrope. EBITDA margin, changes, pp
Neurotrope (NTRP) EBITDA margin US GAAP (quarter values) |
||||||||
2020Q3 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
EBITDA margin, % | ? | -1 247% | -1 320% | -1 322% | -594.3% | -1 102% | ||
Changes by years, y/y, % | ||||||||
Changes by quarters, q/q, % | -73pp | -2pp | +727pp |